These results demonstrate that IGF2BP2 binds to the 3’UTR region of SLC7A5 mRNA and enhances its stability in an m6A-dependent manner, to increase SLC7A5 expression in lung cancer cells. The gene discussed is SLC7A5; the disease is lung cancer.